Quantification of enhancement of left ventricular myocardium in patients with dilated cardiomyopathy using delayed

Eijun Sueyoshi1, Ichiro Sakamoto, Takeshi Hayashida

  • 1Department of Radiology, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan. EijunSueyoshi@aol.com

Insights

Delayed enhancement (DE) magnetic resonance imaging (MRI) reveals higher contrast-to-noise ratio (CNR) in dilated cardiomyopathy (DCM) patients, suggesting fibrosis. This CNR measurement correlates with left ventricular ejection fraction (LVEF), aiding DCM diagnosis.

Area of Science:

  • Cardiovascular Imaging
  • Radiology
  • Cardiac MRI

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Assessing myocardial fibrosis and contractile function is crucial for DCM diagnosis and management.
  • Delayed enhancement (DE) cardiovascular magnetic resonance imaging (CMR) is a key technique for visualizing myocardial tissue characterization.

Purpose of the Study:

  • To evaluate delayed enhancement (DE) in the myocardium of patients with dilated cardiomyopathy (DCM) compared to control subjects.
  • To assess the interrelationships between DE and left ventricular (LV) contractile function in DCM patients.

Main Methods:

  • DE CMR imaging was performed on 42 DCM patients and 14 controls.
  • A two-dimensional segmented inversion-recovery prepared gradient-echo sequence was used 15 minutes after gadolinium administration.
  • Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of the LV myocardium were calculated, along with averaged values (aSNR, aCNR).

Main Results:

  • Mean aSNR did not differ significantly between groups.
  • Mean aCNR was significantly higher in the DCM group (3.5±3.1) versus controls (-4.1±2.1).
  • In DCM patients, aCNR showed a moderate correlation with LV ejection fraction (LVEF) (r=0.52, P<.0001), with higher aCNR in those with low LVEF (<25%).

Conclusions:

  • DE CMR imaging demonstrates a high aCNR in the LV myocardium of DCM patients, indicative of potential fibrosis.
  • Quantification of aCNR is objective and valuable for diagnosing DCM.
  • The level of aCNR correlates with LV contractile function, specifically LVEF.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...